The U.S. Government Quietly Handed Tobacco Companies a Gift. This Has Happened Before.

What Happened

The Trump administration has taken regulatory or policy action favorable to the tobacco industry, representing a significant rollback of restrictions or oversight that had previously been in place or proposed. The NY Times frames this as a product of political friendship and industry lobbying access rather than public health evidence.

Historical Context

The tobacco industry's political reach is not new. Philip Morris and peers spent decades — from the 1950s through the 1990s — successfully delaying regulation despite internal evidence of harm. The FDA didn't gain authority to regulate tobacco products until 2009, under the Family Smoking Prevention and Tobacco Control Act — over 40 years after the Surgeon General's landmark 1964 report. Industry-friendly administrations are a recurring pattern: Reagan-era deregulation, Bush-era delays on menthol bans, and now this. Meanwhile, smoking rates in the U.S. have fallen from ~42% of adults in 1965 to roughly 11% in 2023 — a long, slow, structural decline that no single policy reversal has meaningfully stopped. The industry's long-term trajectory remains downward; its lobbying wins are rearguard actions.

What's In Your Control

Whether you smoke or continue smoking. Whether you hold stock in tobacco companies. Whether you contact your congressional representative if this change affects public health policy you care about. Whether you read the actual regulatory change rather than the newspaper's framing of it.

Does This Require Action?

If you work in public health, advocacy, or are a smoker yourself: this warrants attention. For most readers, awareness is sufficient. You are not required to have a hot take on tobacco lobbying today.